Leishmania major: Molecular modeling of cysteine protease and prediction of new nonpeptide inhibitors

Experimental Parasitology

Volumn 87, Issue 3, 1997, Pages 212-221

  Selzer, Paul M ^a,d,e   Chen, Xiaowu ^b   Chan, Victor J ^a   Cheng, Maosheng ^b   Kenyon, George L ^b   Kuntz, I D ^b   Sakanari, Judy A ^a   Cohen, Fred E ^a,b   McKerrow, James H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CRUZIPAIN; CYSTEINE PROTEINASE; PAPAIN; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; LEISHMANIA MAJOR; MOLECULAR MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

LEISHMANIA MAJOR; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031282334     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1997.4220     Document Type: Article

References (44)

1. Aronson, N. N., and Barrett, A. J. 1978. The specificity of cathepsin b. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism. Biochemical Journal 171, 759-765.
2. Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, G. C., Tamai, M., and Hanada, K. 1982. L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochemical Journal 201, 189-198.
3. Barrett, A. J., and Kirschke, H. 1981. Cathepsin B, cathepsin H, and cathepsin L. Methods in Enzymology 80, 535-561.
4. Bart, G., Cooms, G. H., and Mottram, J. C. 1995. Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin B-like cysteine proteinase. Molecular and Biochemical Parasitology 73, 271-274.
5. Bernstein, F. C., Kotzle, T. F., Williams, G. J., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., and Tasumi, M. 1978. The protein data bank: A computer-based archival file for macromolecular structures. Archives of Biochemistry and Biophysics 185, 584-591.
6. Coombs, G. H., and Baxter, J. 1984. Inhibition of Leishmania amastigote growth by antipain and leupeptin. Annals of Tropical Medicine and Parasitology 78, 21-24.
7. Eakin, A. E., McGrath, M. E., McKerrow, J. H., Fletterick, R. J., and Craik, C. S. 1993. Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi. Journal of Biological Chemistry 268, 6115-6118.
8. Eakin, A. E., Mills, A. A., Harth, G., McKerrow, J. H., and Craik, C. S. 1992. The sequence, organization and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. Journal of Biological Chemistry 267, 7411-7420.
9. Ferrin, T. E., Huang, L. E., Jarvis, L. E., and Langridge, R. 1988. The MIDAS display system. Journal of Molecular Graphics 6, 13-27.
10. Gregoret, L. M., and Cohen, F. E. 1990. Novel method for the rapid evaluation of packing in protein structures. Journal of Molecular Biology 211, 959-974.
11. Grogl, M., Thomason, T. N., and Franke, E. D. 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous diseases. American Journal of Tropical Medicine and Hygiene 47, 117-126.
12. Huang, C. C., Petterson, T. E., Klein, T. E., Ferrin, T. E., and Langridge, R. 1991. Conic: A fast renderer for space-filling molecules with shadows. Journal of Molecular Graphics 9, 230-236.
13. Illy, C., Quraishi, O., Wang, J., Purisima, E., and Vernet, T. 1997. Role of the occluding loop in cathepsin B activity. The Journal of the Biological Chemistry 272, 1197-1202.
14. Jia, Z., Hasnain, S., Hirama, T., Lee, X., Mort, J. S., To, R., and Huber, C. J. 1995. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Journal of Biological Chemistry 270, 5527-5533.
15. Kamphuis, I. G., Kalk, K. H., Swarte, M. B. A., and Drenth, J. 1984. Structure of papain refined at 1.65 angstroms. Journal of Molecular Biology 179, 233-256.
16. Khouri, H. E., Vernet, T., Menard, R., Parlati, F., Laflamme, P., Tessier, D. C., Gour-Salin, B., Thomas, D. Y., and Storer, A. C. 1991. Engineering of papain: selective alteration of substrate specificity by site-directed mutagenesis. Biochemistry 30, 8929-8936.
17. Kirschke, H., Barrett, A. J., and Rawlings, N. D. 1995. Proteinases 1: lysosomal cysteine proteinases. Protein Profile 2, 1581-1643.
18. Knight, C. G. 1995a. Fluorimetric assays of proteolytic enzymes. Methods in Enzymology 248, 18-34.
19. Knight, C. G. 1995b. Active-site titration of peptidases. Methods in Enzymology 248, 85-101.
20. Kuntz, I. D. 1992. Structure-based strategies for drug design and discovery. Science 257, 1078-1082.
21. Kuntz, I. D., Meng, E. C., and Shoichet, B. K. 1994. Structure-based molecular design. Accounts of Chemical Research 27, 117-123.
22. Li, R., Chen, X., Gong, B., Selzer, P. M., Li, Z., Davidson, E., Kurzbahn, G., Miller, R. E., Nuzum, E. O., McKerrow, J. H., Fletterick, R. J., Gillmore, S. A., Craik, C. S., Kuntz, I. D., Cohen, F. E., and Kenyon, I. D. 1996. Structure-based design of parasitic protease inhibitors. Bioorganic & Medicinal Chemistry 4, 1421-1427.
23. Li, R., Kenyon, L., Cohen, F. E., Chen, X., Gong, B., Dominguez, J. N., Davidson, E., Kurzbahn, G., Miller, R. E., Nuzum, E. O., Rosenthal, P. J., and McKerrow, J. H. 1995. In vitro antimalaria activity of chalcones and their derivatives. Journal of Medicinal Chemistry 38, 5031-5037.
24. Li, Z., Chen, X., Davidson, E., Zwang, O., Mendis, C., Ring, C. S., Roush, W. R., Fegley, G., Li, R., Rosenthal, P. J., Lee, G. K., Kenyon, G. L., Kuntz, I. D., and Cohen, F. E. 1994. Anti-malarial drug development using models of enzyme structure. Chemistry & Biology 1, 31-37.
25. Luthy, R., Bowie, J. U., and Eisenberg, D. 1992. Assessment of protein models with three-dimensional profiles. Nature 356, 83-85.
26. Martinelli, J. E., and Chaykovsky, M. 1980. Aromatic chlorination of p-aminobenzoic acid derivatives. Improved synthesis of mono-and dichloromethotrexate. Journal of Organic Chemistry 45, 527-529.
27. Mason, R. W. 1991. Proteinases of mammals: an overview. In "Biochemical Protozoology" (G. H. Coombs and M. J. North, Eds.), pp. 168-179. Taylor & Francis, London, New York, Philadelphia.
28. McGrath, M. E., Eakin, A. E., Engel, J. C., McKerrow, J. H., Craik, C. S., and Fletterick, R. J. 1995. The crystal structure of cruzain: a therapeutic target for Chagas' disease. Journal of Molecular Biology 247, 251-259.
29. McKerrow, J. H., Sun, E., Rosenthal, P. J., and Bouvier, J. 1993. The proteases and pathogenicity of parasitic protozoa. Annual Review of Microbiology 47, 821-853.
30. Moran, J. S., and Bernard, K. W. 1989. The spread of chloroquine-resistant malaria in Africa. Journal of the American Association of Medicine 262, 245-248.
31. Mosimann, S., Meleshko, R., and James, N. G. 1995. A critical assessment of comparative molecular modeling of tertiary structures of proteins. Proteins: Structure, Functions and Genetics 23, 301-317.
32. Mottram, J. C., Souza, A. S., Hutchinson, J. E., Carter, R., Frame, M. J., and Coombs, G. H. 1996. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proceedings of the Academy of Science USA 93, 6008-6013.
33. Musil, D., Zucic, D., Turk, D., Engh, R. A., Mayr, I., Huber, R., Popovic, T., Turk, V., Towatari, T., Katunuma, N., and Bode, W. 1991. The refined 2.15 angstroms x-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO Journal 10, 2321-2330.
34. Ring, C. S., Sun, E., McKerrow, J. H., Lee, G. K., Rosenthal, P. J., Kuntz, I. D., and Cohen, F. E. 1993. Structure-based inhibitor design using protein models for the development of anti-parasitic agents. Proceedings of the National Academy of Sciences of the United States of America 90, 3583-3587.
35. Robertson, C. D., and Coombs, G. H. 1993. Cathepsin B-like cysteine proteases of Leishmania mexicana. Molecular and Biochemical Parasitology 62, 271-280.
36. Robertson, C. D., Coombs, G. H., North, M. J., and Mottram, J. C. 1996. Parasite cysteine proteases. Perspectives in Drug Discovery and Design 6, 99-118.
37. Sakanari, J. A., Nadler, S. A., Chan, V. J., Engel, J. C., Leptak, C., and Bouvier, J. 1997. Leishmania major: Comparison of the cathepsin L-and B-like cysteine protease genes with those of other trypanosomatides. Experimental Parasitology 85, 63-76.
38. Sakanari, J. A., Selzer, P. M., Chan, V., Engel, J., and Bouvier, J. 1995. Parasite proteases as targets for the structure-based approach of drug design. Acta Medica Philippina 31, 188-197.
39. Schechter, I., and Berger, A. 1967. On the size of the active site in proteases. I. Papain. Biochemical and Biophysical Research Communications 27, 157-162.
40. Schweitzer, B. I., Dicker, A. P., and Bertino, J. R. 1990. Dihydrofolate reductase as a therapeutic target. The FASEB Journal 4, 2441-2452.
41. Smyth, D. G., Blumenfeld, O. O., and Konigsberg, W. 1964. Reaction of N-ethylmaleimide with peptides and amino acids. Biochemical Journal 91, 589-595.
42. Storer, A. C., and Menard, R. 1994. Catalytic mechanism in papain family of cysteine peptidases. Methods in Enzymology 244, 486-501.
43. Storer, A. C., and Menard, R. 1996. Recent insights into cysteine protease specificity: lessons for drug design. Perspectives in Drug Discovery and Design 6, 33-46.
44. Turk, D., Podobnik, T., Popovic, T., Katunuma, N., Bode, W., Huber, R., and Turk, V. 1995. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34, 4791-4797.